Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Novartis Opens $1 Billion Shanghai R&D Center

publication date: Jun 2, 2016
Novartis, a Swiss biopharma, opened a $1 billion R&D center in Shanghai that will complement its other two major R&D hubs -- one in its Basel home and the other in Cambridge, Massachusetts. Originally announced in 2009, the facility will house up to 1300 employees. In 2009, Novartis employed just 130 people in its China R&D operation. The new center will focus on treatments for diseases that are prevalent in China and Asia, such as gastric and liver cancer, HBV and hepatic fibrosis. Novartis felt it had to open the China center because of China's scientific talent, said CEO Joe Jimenez. "Not everyone wants to live in Basel," he added. More details....

Stock Symbols: (NYSE: NVS)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital